NanoActive® BAKUCHIOL SALICYLATE: The Next-Gen Retinoid-Alternative for Dual-Action Care
Introduction
As the dermo-cosmetic market shifts towards high-efficacy yet low-irritation solutions, the demand for “Retinol-like” performance without the associated “Retinol burn” has reached a peak. NanoActive® BAKUCHIOL SALICYLATE is a technologically advanced active that bridges the gap between anti-aging and blemish control.
By combining the terpenoid structure of Bakuchiol with the exfoliating and anti-inflammatory properties of Salicylic Acid, and subsequently encapsulating this conjugate within a biomimetic Nano-Delivery System (NDS), we offer a multi-dimensional tool for modern skincare. This system overcomes the inherent hydrophobic nature of the actives, providing a crystal-clear, water-soluble solution that penetrates deeply to reset cellular behavior.
The Technology: Synergistic Molecular Architecture
1. Molecular Functionalization
Unlike simple physical blends, NanoActive® BAKUCHIOL SALICYLATE leverages a synergistic approach where the anti-aging signaling of Bakuchiol and the keratolytic action of Salicylic Acid work in tandem. This conjugation maximizes the inhibition of pro-inflammatory cytokines while stimulating dermal matrix synthesis.
2. Nano-Encapsulation (NDS)
The active is embedded in a phospholipid-based nanosphere (average size < 100 nm). This provides:
- Superior Stability: Prevents photo-oxidation and degradation.
- Enhanced Bioavailability: Significant increase in transdermal flux compared to free-form Bakuchiol.
- Non-Irritating Profile: Slow-release mechanism reduces the acute irritation often associated with salicylic acid, making it suitable for sensitive skin.
Biological Mechanisms & Efficacy
1. Dermal Matrix Restructuring
NanoActive® BAKUCHIOL SALICYLATE acts on the same gene pathways as Retinoids, upregulating Type I Collagen (COL1A1) and Type III Collagen, while suppressing the activity of MMP-1 to prevent collagen breakdown. It effectively reduces fine lines and improves skin elasticity.
2. Targeted Blemish Control & Pore Refinement
The salicylic acid moiety provides precise keratolytic action, clearing follicular debris. Simultaneously, the Bakuchiol component regulates sebum composition and inhibits the proliferation of Cutibacterium acnes, making it the ideal solution for adult acne and “maskne.”
3. Anti-Inflammatory & Soothing
By inhibiting the NF-κB signaling pathway, it calms chronic micro-inflammation (Inflamm-aging), reducing erythema and post-inflammatory hyperpigmentation (PIH).
Technical Specifications
Strategic Applications
- Retinol-Alternative Elixirs: For consumers seeking ageless skin without the downtime of retinoids.
- Blemish & Age Intercept Serums: Specifically designed for adult acne and skin texture refinement.
- Glass Skin Foundations: Incorporating treatment benefits into high-clarity aqueous makeup bases.
- Post-Procedure Recovery: To soothe and prevent pigmentation in sensitive skin types.
Disclaimer: This document is intended for B2B purposes only. All claims must be verified by the final formulator in accordance with regional cosmetic regulations.
Pioneering the Future of Skincare Efficacy
At PuriPharm, we bridge the gap between advanced biomedical science and transformative cosmetic solutions. As a leading innovator in active ingredients and delivery architectures, we empower global personal care brands to achieve unprecedented clinical efficacy. Our core philosophy is built on two pillars: extracting the absolute potential of bioactive molecules, and ensuring their precise delivery to the target site.
Our Core Technology Matrix
PuriPharm’s innovation engine is driven by two flagship platforms, designed to work independently or in powerful synergy to elevate your formulations.
1. PuriActives®: The Pinnacle of Biological Efficacy
PuriActives® represents our premier line of highly purified, biologically active compounds. Rooted in synthetic biology, advanced fermentation, and precision extraction technologies, the PuriActives® portfolio delivers potent, mechanism-driven ingredients.
- Uncompromised Purity: Rigorous isolation processes ensure that only the most active molecules are retained, minimizing impurities and maximizing safety.
- Mechanism-Driven: Each active is developed with a clear understanding of cellular pathways, offering targeted solutions for anti-aging, pigmentation control, skin barrier repair, and microbiome balance.
- Sustainable Sourcing: Inspired by nature and optimized in the lab, we minimize ecological impact while delivering consistent, scalable results.
Key Applications: Bio-mimetic Peptides, Recombinant Proteins, High-purity Botanical Extracts.
2. NanoActive®: Precision Delivery, Amplified Performance
The most potent active ingredient is only as effective as its ability to reach its target. NanoActive® is our proprietary, state-of-the-art nanotechnology delivery platform, engineered to overcome the thermodynamic and physiological barriers of the stratum corneum.
- Enhanced Bioavailability: Utilizing advanced liposomal, solid lipid nanoparticle (SLN), and nano-emulsion architectures, NanoActive® dramatically increases the solubility and skin penetration of challenging active molecules.
- Controlled & Sustained Release: Our carrier systems are designed for spatio-temporal precision, releasing the actives gradually to ensure long-lasting efficacy and lower irritation profiles.
- Formulation Stability: By encapsulating sensitive compounds (e.g., Retinol, Vitamin C, Resveratrol), NanoActive® shields them from oxidation, light, and formulation incompatibilities, extending product shelf life.
The Science of Delivery: Nanostructured Lipid Carriers (NLC), Multi-lamellar Liposomes, Micro-sponges.
The Synergy of Science and Business
At PuriPharm, we do more than supply ingredients; we provide architectural solutions for your formulations. Whether you require the potent biological triggers of PuriActives® or the sophisticated delivery mechanisms of NanoActive®—or a customized integration of both—our team of scientists and market experts is ready to co-create your next hero product.
PuriPharm Co. Ltd. Innovating Molecules. Architecting Delivery. Transforming Beauty.
NanoActive® BAICALIN
A New Era in Telomerase-Targeted Anti-Aging: Ultimate Repair at the Cellular Core
PURIPHARM: PIONEERS IN DELIVERY INNOVATION
Leading the “Transdermal Delivery” Revolution
PuriPharm is dedicated to the efficient delivery of biological active ingredients. The NanoActive® platform, driven by our proprietary NDS (Nano Delivery System) technology, overcomes the traditional limitations of active compounds regarding stability, solubility, and permeability.
Focus on nano-encapsulation of bioactives.
Pharmaceutical-grade R&D and manufacturing standards.
Empowering premium global cosmetic brands.
BAICALIN: NATURE’S “LONGEVITY FACTOR”
Modern Science from Traditional Medicine
Extracted from the roots of Scutellaria baicalensis, Baicalin is widely recognized in dermatology as a highly potent, multi-functional active ingredient. Extensive SCI research confirms its superior performance in delaying cellular senescence, neutralizing free radicals, and repairing UV damage.
Key Profile: A high-purity flavonoid compound and a natural telomerase activator.
TRADITIONAL CHALLENGES: FORMULATION BOTTLENECKS
THE NANOACTIVE® SOLUTION
Driven by Molecular Motor Technology
NanoActive® BAICALIN utilizes ATP synthase molecular motor technology to encapsulate active molecules within biological microcapsules that highly simulate cellular membrane structures.
Particle Size: 10-100nm, increasing transdermal delivery by 500%.
Stability: Enhances anti-oxidative degradation capacity by more than 10 times.
Solubility: 100% highly water-soluble for crystal-clear formulations.
Core Mechanism: Molecular Targeted Repair
TELOMERASE: THE “BIOLOGICAL CLOCK”
Breaking the Hayflick Limit
Telomeres are protective caps located at the ends of chromosomes that shorten with each cell division. Once telomeres are depleted, the cell enters a state of irreversible “Senescence”.
Telomerase is the only crucial enzyme capable of replenishing telomere length and resetting cellular lifespan. Baicalin is proven to be one of the very few natural small molecules capable of effectively activating this enzyme.
CORE MECHANISM: ACTIVATING HTERT EXPRESSION
DEFENDING AGAINST PHOTOAGING: UVA/UVB PROTECTION
MOLECULAR TARGETS: REGULATING P53/P16 SIGNALING
IN VITRO: SIGNIFICANT ROS SCAVENGING
IN VITRO: PROMOTING FIBROBLAST PROLIFERATION
IN VITRO: DNA DAMAGE REPAIR (Γ-H2AX)
Clinical Research: Efficacy Validation
CLINICAL: MULTI-DIMENSIONAL WRINKLE REDUCTION
CLINICAL: ENHANCING ELASTICITY & FIRMNESS
CLINICAL: IMPROVING TEXTURE & REFINEMENT
COMPARISON: NANOACTIVE® VS TRADITIONAL
FORMULATION GUIDELINES: STABILITY & COMPATIBILITY
SAFETY & COMPLIANCE: RIGOROUS STANDARDS
Redefining High-End Anti-Aging Actives
NanoActive® BAICALIN is more than just an antioxidant; it is a molecular bridge across the Hayflick limit. Through precise targeting of telomerase, we enable skin cells to recapture the metabolic vitality of their youth.
NanoActive® BAICALIN: The Intelligent “Telomerase” Activator for Cellular Youth
Unleashing Baicalin’s Cellular Anti-Aging Potential through Advanced Nano-Targeted Delivery
1. Discovering Nature’s Time Code: Baicalin & The Delivery Bottleneck
Scutellaria baicalensis Georgi has long been revered as a “Golden Herb” in traditional Eastern medicine. Its core polyphenolic flavonoid active—Baicalin—has been extensively validated by top-tier SCI journals (e.g., Journal of Investigative Dermatology, Free Radical Biology and Medicine) for its outstanding pharmacological properties, including ROS scavenging, MMPs inhibition, and broad-spectrum UV protection.
However, in modern dermatology and premium cosmetic applications, unmodified Baicalin faces a notoriously difficult translational gap: stellarin vitrodata, but mediocrein vivoefficacy. This is driven by three critical challenges:
- High Crystallinity & Poor Solubility: Highly prone to crystallization and precipitation in cosmetic emulsions or serums, making it impossible to maintain at high free-state concentrations.
- Extreme Physicochemical Instability: Containing multiple oxidation-prone phenolic hydroxyl groups, it easily browns and develops off-odors when exposed to light, heat, or mildly alkaline formulations.
- Extremely Low Bioavailability: Its large molecular polarity means it is heavily blocked by the dense “brick-and-mortar” structure of the Stratum Corneum, failing to penetrate into the dermis to exert gene-level targeted effects.
PuriPharm: The NanoActive® Targeted Intelligent Delivery Solution
Fusing biomimetic medicine with nanofluidic dynamics, PuriPharm utilizes its proprietary NanoActive® encapsulation technology. We have constructed Multilamellar Vesicles that highly mimic the structure of human cell membranes, precisely and stably embedding high-purity Baicalin within an amphiphilic nano-bilayer structure.
This breakthrough technology completely dismantles Baicalin’s physical barriers, achieving a systemic quadruple leap: High Solubility, Supreme Stability, Targeted Deep Penetration, and Prolonged Sustained Release.
2. Core Mechanism of Action (MoA): Targeting the Root of Cellular Senescence
Leveraging the highly efficient transmembrane fusion capabilities of the NanoActive® carrier, Baicalin can reach efficacious therapeutic concentrations inside living cells, exerting critical regulatory roles across three cutting-edge anti-aging pathways:
2.1 Targeted Telomerase Activation, Guarding the DNA Terminal Lifeline
Nobel Prize-winning research indicates that replicative cellular senescence is dictated by the “biological clocks” at the ends of chromosomes—Telomeres. UV irradiation and chronic oxidative stress dramatically accelerate telomere shortening, leading to irreversible cellular senescence.
- Upregulation of TERT Genes: NanoActive® BAICALIN penetrates deep into the nucleus to specifically activate or maintain the expression levels of Telomerase Reverse Transcriptase (TERT).
- Rescuing G1 Phase Arrest: It significantly downregulates core senescence switch genes p53 and p16INK4a (induced by DNA damage), enabling dormant senescent cells to regain their capacity for division and self-renewal, effectively turning back the clock at the genetic level.
2.2 Reversing SASP (Senescence-Associated Secretory Phenotype) — Cellular “Senomorphics”
In modern anti-aging medicine, clearing or modifying the toxic factors secreted by senescent cells (SASP, e.g., IL-6, IL-8, MMPs) is the most sought-after strategy.
NanoActive® BAICALIN demonstrates potent “Senomorphic” activity. It strongly inhibits the NF-κB inflammatory signaling pathway, severing the contagious cascade of SASP that destroys the surrounding healthy Extracellular Matrix (ECM), thereby protecting the Type I and Type III collagen networks.
2.3 Awakening the Nrf2/ARE Antioxidant Master Switch
Transcending the limitations of traditional antioxidants (like Vitamin C and E) which consume themselves in a 1:1 ratio with free radicals, NanoActive® BAICALIN acts as an “ignition key” for the cell’s endogenous defense mechanisms. By dissociating the Keap1-Nrf2 complex, it promotes Nrf2 nuclear translocation and binding to the ARE sequence, exponentially amplifying the expression of endogenous antioxidant enzymes (SOD, CAT, GSH-Px).
3. Outstanding Scientific Efficacy: Defining Anti-Aging Limits with Data
3.1 Nano-Targeted Delivery & Kinetics
Experiment A: HaCaT Cellular Internalization
Assessed using fluorescent probes (Coumarin-6) combined with flow cytometry and confocal microscopy.
●Results: After a 2-hour incubation, the absolute intracellular fluorescence intensity of the NanoActive® group was 4.2 times higher than that of the unencapsulated free Baicalin group. The biomimetic liposomes seamlessly fused via endocytosis, achieving highly efficient “targeted airdrops.”
Experiment B: Franz Diffusion Cell & Higuchi Release Model
●Penetration: The cumulative amount of Baicalin penetrating the porcine ear epidermis into the receptor fluid over 24 hours was 8.5 times greater for NanoActive® BAICALIN compared to standard Baicalin raw materials.
●Release Profile: The release curve perfectly aligns with the Higuchi Diffusion Equation (R² > 0.98), exhibiting characteristic matrix-type sustained release. It delivers a steady release over 24 hours, avoiding the “peak and valley” effect of drug concentration to ensure long-lasting, gentle, and effective results.
3.2 In Vitro & 3D Ex Vivo Skin Models
Experiment C: Fibroblast Telomerase Activity Protection (TRAP Assay)
Human primary fibroblasts were exposed to a UVA photo-damage model.
●Results: UVA reduced fibroblast telomerase activity to 31.2% of the normal group. Following pretreatment with NanoActive® BAICALIN, telomerase activity recovered to 63.9%, confirming its direct protective effect on the TERT mechanism.
Experiment D: 3D Full-Thickness Skin Model Remodeling
Continuous topical application of the test substance on a reconstructed 3D skin model for 7 days.
●Results: H&E staining and immunofluorescence of tissue sections showed that, compared to the control group, the NanoActive® BAICALIN treated group exhibited a 17% increase in epidermal thickness, a 145% enhancement in the fluorescence expression intensity of Pro-collagen I in the dermis, and a significantly denser and more undulated Dermal-Epidermal Junction (DEJ) architecture.
3.3 In Vivo Clinical Efficacy
●Study Design: A randomized, double-blind, placebo-controlled clinical trial. 35 female subjects aged 35-55 with moderate photoaging and wrinkles applied a base cream containing 2% NanoActive® BAICALIN to half of their face twice daily for 56 days. Instrumental evaluations included VISIA®-CR, Cutometer®, and high-frequency skin ultrasound.
Core Clinical Data:
- Leap in Dermal Density (Skin Density via Ultrasound): Evaluated using a 20 MHz high-frequency ultrasound scan. After 56 days of use, the dermal density significantly increased by 19.3% (measured by the reduction of the Subepidermal Low Echogenic Band, SLEB), proving substantial remodeling of the collagen network.
- Deep Wrinkle Reduction & Smoothing: Maximum depth of crow’s feet wrinkles (Rz) was reduced by 22.4%, and skin roughness (Ra) decreased by 16.5%.
- Potent Soothing & Anti-Inflammaging (Erythema Index): The skin Erythema Index showed a significant drop as early as day 14 (-11%), with a cumulative reduction of 18% over 56 days, clinically validating its soothing efficacy against micro-inflammation induced by SASP.
4. Technical Advantages & Formulation Guidelines
NanoActive® BAICALIN is a “plug-and-play” bioactive designed for high-end skincare products pursuing ultimate clinical efficacy.
- INCI Name: Scutellaria Baicalensis Root Extract
- Appearance: Light yellow to brownish-yellow translucent nano-fluid.
- Particle Size: 10-100nm (DLS detection, PDI < 0.2). This ultra-small particle size is the core of its transparent appearance and deep transdermal penetration.
- Superior Formulation Compatibility:
- Disperses perfectly in the aqueous phase; zero crystallization or precipitation over time.
- Broad pH tolerance range (pH 4.0 – 7.5).
- Ease of Use: Cold processable; can be added directly to the water phase. For hot emulsion systems, addition is recommended during the cooling phase post-homogenization (< 45°C).
●Extreme Stability Challenge: Under accelerated testing for 3 months at 40°C and 5000 Lux illumination, the active retention rate of Baicalin in NanoActive® BAICALIN was> 95%, with zero browning and zero off-odors (Note: unencapsulated Baicalin severely degrades and discolors within 15 days under identical conditions).
Market Positioning & Applications (Claims):
- Recommended Dosage: Daily maintenance and early anti-aging (0.5% – 2.0%); Targeted telomerase activation, intensive anti-wrinkle, and photo-damage repair (2.0% – 5.0%).
- Marketing Claims: Telomerase Guardian, Cellular Longevity Extension, Senolytics/Senomorphics, Photoaging Reversal, Non-Destructive Deep Delivery.
- Applicable Formats: Premium anti-aging creams, gene-repair base serums, high-potency antioxidant sunscreens, post-microneedling/laser wound-healing serums, luxury scalp anti-aging and anti-hair-loss tonics.
NanoActive® BAICALIN— The underlying engine for international cutting-edge cellular skincare.
Researched and Manufactured by PuriPharm. Fusing macromolecular delivery kinetics with systems biomedicine to rewrite time and unlock the secrets of ageless skin.
NanoActive BENZYL URSOLATE
The Next-Generation Dermal Architect: Precision-Delivered Triterpenoid for Profound Skin Rejuvenation
1. Product Overview
In the pursuit of ultimate skin longevity, unlocking the full potential of natural triterpenoids has been a long-standing challenge due to their inherent insolubility and limited skin penetration.
NanoActive BENZYL URSOLATE represents a breakthrough in active ingredient bio-engineering. By synergizing targeted molecular modification (benzyl esterification of ursolic acid) with advanced sub-micron encapsulation technology, we have created a highly bioavailable, potent, and stable anti-aging active. It fundamentally restores Extracellular Matrix (ECM) homeostasis, offering unparalleled firming, anti-wrinkle, and skin-redensifying benefits.
2. The Science: Mechanism of Action
Standard ursolic acid struggles to cross the stratum corneum. NanoActive BENZYL URSOLATE overcomes this through a dual-action optimization strategy:
- Molecular Prodrug Strategy: The attachment of a benzyl group enhances the lipophilicity of the ursolic acid core. Upon penetrating the skin, endogenous epidermal esterases gradually cleave the ester bond, ensuring a sustained and controlled release of the active aglycone directly within the dermal-epidermal junction (DEJ).
- Nanostructured Lipid Delivery: Encapsulated within a phospholipid-based nanocarrier system (< 100 nm), the active is shielded from premature degradation. The biomimetic lipid bilayer structure merges seamlessly with the stratum corneum intercellular lipids, facilitating deep transfollicular and intercellular penetration.
- ECM Remodeling & Pathway Regulation: Once delivered to the fibroblasts, it acts as a robust inhibitor of Matrix Metalloproteinases (specifically MMP-1 and MMP-9) and human leukocyte elastase (HLE). Simultaneously, it upregulates the synthesis of Collagen I, Collagen III, and ceramides, reversing chronological and photo-induced structural degradation.
3. Key Efficacy Highlights
- Profound Wrinkle Reduction: Visibly diminishes the depth and volume of crow’s feet and nasolabial folds by restructuring the dermal fiber network.
- Enhanced Skin Biomechanics: Significantly improves skin elasticity and firmness, combating gravity-induced sagging.
- Barrier Restoration: Stimulates endogenous ceramide production, reinforcing the skin’s natural lipid barrier and reducing Transepidermal Water Loss (TEWL).
- Inflammaging Defense: Exhibits potent anti-inflammatory properties by modulating COX-2 pathways, soothing micro-inflammation that accelerates cellular aging.
4. Technical Data & Formulation Guidelines
Designed with the formulator in mind, NanoActive BENZYL URSOLATE integrates seamlessly into modern cosmetic chassis.
- INCI Name: Water, Glycerin, Caprylic/Capric Triglyceride, Phospholipids, Benzyl Ursolate
- Appearance: Translucent to slightly opalescent fluid.
- Solubility: Water-dispersible (forms stable nano-emulsion).
- Recommended Usage Level: 1.0% – 5.0%
- pH Stability Range: 4.5 – 6.5
- Formulation Advice: Add during the cooling phase (below 45°C) to preserve the integrity of the liposomal structures. Avoid high-shear homogenization after addition. Compatible with most emulsifiers, polymers, and other anti-aging actives (e.g., Peptides, Niacinamide).
5. Ideal Applications
- Intensive Anti-Aging Serums & Ampoules
- Skin Contouring and Firming Creams
- Post-Procedure Barrier Repair Lotions
- Premium Eye Care Formulations
Elevate your formulations with the precision of science. Contact our technical sales team for in-vivo efficacy data, clinical brochures, and sample requests.
PuriActives® Ursolene™ BZ
Precision-Engineered Triterpenoid: The Cornerstone of Deep Dermal Rejuvenation & Structural Reconstruction
The Botanical Bottleneck
Natural pentacyclic triterpenes like Ursolic Acid possess exceptional biological activities, but face severe cosmetic limitations:
Extremely poor lipophilicity restricts formulation versatility.
Low skin penetration limits clinical bioavailability.
High propensity to crystallize destabilizes emulsions.
The Solution: By introducing a benzyl group, we fundamentally shift the molecule’s partition coefficient, creating a highly bioavailable, oil-soluble powerhouse.
Mechanism of Action
Bioavailability Shift
The structural transformation from Ursolic Acid to Ursolene™ BZ is rooted in a fundamental alteration of the lipid-water partition coefficient.
This precise structural modification transforms a traditional botanical extract into a pharmaceutical-grade, oil-soluble active that seamlessly crosses the stratum corneum to reach deep dermal targets.
In Vitro Efficacy
Dermal Architecture Support
Our rigorous efficacy testing matrix demonstrates statistically significant improvements compared to vehicle and unmodified free ursolic acid controls.
Tested on primary human fibroblasts at 10 μM concentration (p < 0.01). The dramatic reduction in UV-induced elastase activity ensures the preservation of the skin’s vital recoil capacity.
In Vivo Clinical Results
A double-blind, placebo-controlled clinical study on 30 female volunteers (aged 45-65), applying a 0.2% PuriActives® Ursolene™ BZ cream twice daily for 28 days.
Stability Comparison
Comparative analysis of formulation stability and lipid solubility scores (measured as a relative percentage of an ideal oil-soluble active profile).
Technical Guidelines
Sustainable Sourcing
Target Applications
The perfect synergy of a naturally derived core and rational structural design, bridging the gap between pharmaceutical-grade precision and cosmetic applicability.
PuriActives® Ursolene™ BZ (Benzyl Ursolate)
Precision-Engineered Triterpenoid: The Cornerstone of Deep Dermal Rejuvenation & Structural Reconstruction
1. Product Overview
While natural pentacyclic triterpenes (like Ursolic Acid) are renowned for their exceptional biological activities, their cosmetic application has historically been bottlenecked by extremely poor lipophilicity, low skin penetration, and formulation instability (propensity to crystallize).
Enter PuriActives® Ursolene™ BZ (INCI: Benzyl Ursolate). By introducing a benzyl group to the ursolic acid backbone, we have fundamentally shifted the molecule’s partition coefficient ( log P). This precise structural modification transforms a traditional botanical extract into a highly bioavailable, oil-soluble powerhouse. It precisely targets the Extracellular Matrix (ECM) architecture, offering a definitive solution for intrinsic/extrinsic aging, loss of elasticity, and compromised skin barriers.
The Core Edge: The perfect synergy of a naturally derived core and rational structural design, bridging the gap between pharmaceutical-grade precision and cosmetic applicability.
2. Key Biological Pathways & Mechanism of Action
PuriActives® Ursolene™ BZ operates through a multi-target mechanism, mitigating tissue senescence at the cellular level:
MMP Modulation & ECM Protection: Acts as a potent competitive inhibitor of Matrix Metalloproteinases (specifically MMP-1 and MMP-9), halting the enzymatic degradation cascade of collagen and elastin networks.
Fibroblast Activation via TGF-β Pathway: Stimulates the transforming growth factor-beta (TGF-β) signaling pathway, upregulating COL1A1 and COL3A1 gene expression to drive the de novo synthesis of structural proteins.
Inflammaging Mitigation: Suppresses the cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) pathways, interrupting the chronic micro-inflammatory cascades that accelerate tissue aging.
Epidermal Lipid Biosynthesis: Upregulates serine palmitoyltransferase (SPT) activity, driving endogenous ceramide production to fortify the stratum corneum barrier.
3. Proven Efficacy (In Vitro & In Vivo Highlights)
Our rigorous efficacy testing matrix demonstrates statistically significant improvements compared to vehicle and unmodified free ursolic acid controls.
In Vitro: Dermal Architecture Support
- + 42% Increase in Pro-collagen I synthesis (Primary human fibroblasts, at 10μM, ).
- – 65% Reduction in UV-induced elastase activity, effectively preserving skin recoil capacity.
In Vivo Clinical Study: Facial Micro-Topography (28-Day Study)
A double-blind, placebo-controlled clinical study on 30 female volunteers (aged 45-65), applying a 0.2% PuriActives® Ursolene™ BZ cream twice daily.
● Wrinkle Depth (Ra): Significant reduction of 21.4% in the periocular region.
● Skin Density: Ultrasound imaging revealed a +15% increase in dermal echogenicity, indicating structural redensification of the dermis.
4. Formulation & Technical Guidelines
PuriActives® Ursolene™ BZ is engineered for the ultimate formulator experience. Its esterified structure completely circumvents the notorious crystallization issues of free ursolic acid, enabling the creation of highly stable, cosmetically elegant emulsions.
● INCI Name: Benzyl Ursolate
● Appearance: White to off-white crystalline powder
● Solubility: Soluble in cosmetic esters (e.g., Caprylic/Capric Triglyceride, Squalane), ethanol, and glycols. Insoluble in water.
● Recommended Usage Level: 0.05% – 0.30%
● Formulation Integration: Add to the heated oil phase ( 70~80℃ ) and stir until fully dissolved before emulsification.
● Optimal pH Range: 4.5 – 6.5
5. Sustainability & Purity
PuriActives® Ursolene™ BZ is derived from upcycled apple pomace and rosemary extract precursors, synthesized via a highly efficient, atom-economical esterification process. We guarantee an ultra-high purity active (HPLC ＞ 95%) while minimizing our environmental footprint.
Recommended Applications:
● Premium Anti-Aging Night Creams
● Intensive Barrier Repair Serums
● Dermo-cosmetics (Post-Procedure Care)
● Sun Recovery & “Anti-Inflammaging” Formulations
NanoActive DHM
NanoActive DHM Epigenetic Youth Restorer & DNA Methylation Inhibitor
1. PRODUCT IDENTIFICATION
- Product Name: NanoActive DHM
- Trade Name: NanoActive DHM by PuriPharm
- INCI Name: Water, Glycerin, Caprylic/Capric Triglyceride, Ampelopsis Grossedentata Extract, Phospholipids, Tocopheryl Acetate.
- Botanical Source of Active: Ampelopsis grossedentata(Vine Tea)
- Active Content: 9.5% – 10.5% (Ampelopsis Grossedentata Extract)
2. PRODUCT DESCRIPTION
NanoActive DHM represents a paradigm shift in epigenetic anti-aging. Developed by PuriPharm Co. Ltd., it is the industry’s first cosmetically viable DNA methylation inhibitor. Utilizing advanced nanoliposomal technology, highly purified Dihydromyricetin (DHM) is encapsulated in a biomimetic phospholipid bilayer. This sophisticated delivery system overcomes the inherent instability and poor skin penetration of DHM, allowing for targeted delivery to the deep epidermis and dermis, fundamentally reversing cellular aging at the genetic transcription level.
3. MECHANISM OF ACTION
Environmental stressors (UV, pollution) and intrinsic aging lead to hypermethylation of DNA, which functionally “silences” essential youth and structural genes.
- Epigenetic Reversal: NanoActive DHM acts as a potent DNA methylation inhibitor, effectively removing age-induced methyl tags.
- Gene Reactivation: By modulating over 10,000 methylation sites, it reactivates silenced genes associated with the Extracellular Matrix (ECM), signal transduction, and autophagy.
- Targeted Delivery: The 50-150 nm liposomal spheres ensure enhanced transdermal absorption and a sustained-release profile, maximizing biological availability and minimizing potential irritation.
4. TECHNICAL SPECIFICATIONS
5. EFFICACY & CLINICAL DATA SUMMARY
- Transcriptomic Upregulation: Significantly upregulates key structural genes including COL6A1 (Collagen Type VI), ITGB6, ITGA5, and VCL, restoring cellular anchorage and tissue firmness.
- 3D Skin Equivalent Model: In a 6-week in vitrostudy utilizing 20µM DHM on mature 3D skin models, NanoActive DHM effectively reversed epidermal thinning. Epidermal thickness increased from 30µm (untreated mature control) to ~50µm, closely mirroring the baseline of young skin models (60µm). Statistical significance achieved (p = 0.00064).
6. FORMULATION GUIDELINES
NanoActive DHM is designed for ease of use in premium cosmetic formulations.
- Recommended Usage Level: 1.0% – 5.0%
- Incorporation Phase: Add to the aqueous phase or during the cooling phase (below 45°C) for emulsions to maintain liposomal integrity.
- pH Compatibility: Stable within a final formulation pH range of 4.5 – 7.5.
- Incompatibilities: Avoid high concentrations of strong ionic surfactants or extreme ethanol levels (>20%) which may disrupt the lipid bilayer.
- Processability: Do not subject to intense, prolonged shear force (homogenization > 3000 rpm for extended periods) after incorporation.
7. TARGET APPLICATIONS
- Premium Anti-Aging Skincare: Serums, night creams, and eye treatments targeting chronological aging and photoaging.
- Medical Aesthetics Post-Care: Restorative formulations designed to prolong the effects of clinical treatments by maintaining epigenetic cellular health.
- Preventative Aging: Solutions targeting millennials/Gen-Z exposed to urban pollution, stress, and lifestyle-induced epigenetic damage.
8. STORAGE & SHELF LIFE
- Storage Conditions: Store in a cool, dry place away from direct sunlight. Recommended storage temperature: 4°C – 25°C. Do not freeze. Keep containers tightly sealed when not in use.
- Shelf Life: 24 months from the date of manufacture under optimal storage conditions.
Disclaimer: The information provided herein is based on our current knowledge and rigorous scientific testing. It is intended for informational purposes for cosmetic professionals and formulators. It is the responsibility of the formulator to ensure the stability, safety, and regulatory compliance of the final consumer product.
PuriPharm Co. Ltd.Pioneering Epigenetic Skincare SolutionsWebsite: www.puriactives.com | Email: service@puripharm.com
NanoActive DHM
1. Epigenetics and Skin Aging
What is Epigenetics?
Epigenetics is the science studying how lifestyle and environmental factors influence gene expression.
This process occurs without changing the underlying DNA sequence.
Instead, it alters gene activity by turning genes “on” or “off” based on external stimuli.
It provides a profound new target for anti-aging interventions by addressing the root causes of cellular decline.
The Identical Twins Study
Primary Drivers of Skin Aging
The Process of DNA Methylation
Lifestyle and environmental factors influence gene expression primarily through DNA methylation.
Methyl groups (epigenetic factors) attach to the DNA molecule.
These methylation marks can activate or, more commonly in aging, improperly repress or “silence” specific genes.
This makes the DNA inaccessible to the machinery that keeps cells youthful and functional.
Hypermethylation and Aging
2. The DHM Breakthrough
Introducing Dihydromyricetin: The world’s first cosmetic DNA methylation inhibitor.
A Global Innovation
Dihydromyricetin (DHM)：
NanoActive DHM features Dihydromyricetin, globally recognized as the first cosmetic ingredient scientifically proven to inhibit DNA methylation. This represents a paradigm shift, leading a completely new direction in epigenetic anti-aging interventions.
Mechanism of Action
Inhibit Methylation: DHM acts directly at the genetic level to regulate and inhibit the excessive DNA methylation patterns that accumulate over time.
Reactivate Youth Genes: By removing these inhibitory methyl tags, DHM successfully reactivates silenced youth genes.
Restore Vitality: This fundamentally delays cellular aging by returning skin cells to their peak functional state, rather than just treating surface symptoms.
Natural Plant Source
NanoActive DHM is extracted exclusively from Ampelopsis Grossedentata, commonly known as Vine Tea.
It belongs to the Vitaceae family, Ampelopsis genus.
This specific plant is exceptionally rich in naturally occurring Dihydromyricetin.
It provides a clean, sustainable, and highly potent botanical source for epigenetic anti-aging formulations.
Cultivation & Extraction
3. Advanced Nanoliposome Technology
Nanoliposome Principles
Definition: Nanoliposomes are microscopic vesicles composed of phospholipid bilayers that perfectly mimic the human cell membrane structure.
Average Size: Ranging from 10 to 50 nm, they are perfectly sized to penetrate the skin barrier effectively.
Encapsulation: They possess a high drug entrapment efficiency, capable of securely encapsulating both hydrophobic and hydrophilic active ingredients like DHM.
Technology Advantages
The Dual Breakthrough
4. Clinical Efficacy and Validation
DNA Methylation Impact
Reversing the Clock
Under experimental conditions (20µM DHM over 6 weeks on a skin equivalent model), DHM treatment significantly affected over 10,000 methylation sites. It successfully induced a young epidermal DNA methylation pattern, restoring youthful epigenetic characteristics.
Epidermal Structure Improvement
Reactivation of Youth Genes
5. Market Application & Value
Competitive Advantage
Target Market & Applications
NanoActive™ DCP Advanced Liposomal Dimethylmethoxy Chromanyl Palmitate
Next-Generation Targeted Delivery for Flawless, Radiant Skin
Product Overview
In the pursuit of safe and highly effective skin depigmentation, the delivery system is just as crucial as the active molecule itself. NanoActive™ DCP represents a paradigm shift in cosmetic skin brightening. By encapsulating the potent, photo-protective brightening agent—Dimethylmethoxy Chromanyl Palmitate—within an advanced nanoscale liposomal carrier, we have solved the traditional challenges of cutaneous penetration and active stability.
Designed for premium anti-aging and skin-illuminating formulations, this branded ingredient offers unparalleled bioavailability. It delivers the active compound precisely to the basal layer where melanocytes reside, unleashing peak biological activity at the nanoscale (the NanoActive™ advantage).
Technical Identity
- Trade Name: NanoActive™ DCP
- INCI Name: Water (and) Glycerin (and) Phospholipids (and) Dimethylmethoxy Chromanyl Palmitate
- Appearance: Translucent to clear pale yellow liquid
- Solubility: Water-dispersible
- Recommended Usage Level: 1.0% – 5.0%
The Science: Mechanism of Action
Our proprietary liposomal technology bridges the gap between biological potential and clinical efficacy through a dual-action mechanism:
1. The Active: Precision Tyrosinase Inhibition
At the core of NanoActive™ DCP is Dimethylmethoxy Chromanyl Palmitate, a clinically validated, non-cytotoxic molecule that effectively inhibits human tyrosinase—the rate-limiting enzyme in melanogenesis. Unlike traditional agents like Hydroquinone, it exhibits no cellular toxicity and offers a significant photo-protective effect against UV-induced cellular damage, preventing premature photo-aging while correcting hyperpigmentation.
2. The Vector: Liposomal Transdermal Delivery
The human stratum corneum is a formidable barrier to hydrophobic molecules. Our advanced liposomes, composed of biocompatible phospholipids, mimic the skin’s natural lipid bilayer.
- Enhanced Penetration: The nanoscale vesicles effortlessly fuse with the cellular membranes of the epidermis, facilitating deep tissue penetration.
- Sustained Release: The liposomal matrix provides a controlled, time-released effect, maintaining optimal active concentrations at the target site over an extended period.
- Superior Stability: Encapsulation protects the active core from oxidation and formulation incompatibilities, ensuring maximum potency from the laboratory to the consumer.
Key Formulator Benefits & Claims
- Clean Beauty Compliant & Self-Preserving: Formulated entirely without conventional preservatives, this ingredient leverages an optimized, low-water-activity matrix for inherent microbiological stability. It perfectly aligns with strict “Clean Label” standards (e.g., Credo, Sephora Clean), reducing regulatory hurdles and formulation complexity for brand owners.
- Perfect Clear-System Compatibility: Perfectly compatible with clear aqueous formulations. Its precise nanoscale dimensions evade Mie scattering, enabling the creation of completely transparent serums, high-performance toners, and ampoules without introducing turbidity.
- Exceptional Thermodynamic Stability: Engineered for extreme resilience. NanoActive™ DCP withstands rigorous Freeze-Thaw Cycle Tests without demulsification, phase separation, or significant particle size growth, guaranteeing robust shelf-life and global supply chain reliability.
- Visible Brightening & Tone Evening: Significantly reduces the appearance of age spots, melasma, and post-inflammatory hyperpigmentation (PIH).
- Photo-Protection & Anti-Aging: Fights reactive oxygen species (ROS) and protects cells from UV-mediated damage.
- Unmatched Safety Profile: Non-irritating, non-sensitizing, and free from the cytotoxic side effects associated with conventional lightening agents.
- Formulation Elegance: Easy to incorporate into aqueous phases at the end of the manufacturing process (cold processable).
Cosmetic Applications
Ideal for premium dermatological and cosmetic formulations aimed at global skin tone improvement:
- Intensive Brightening Serums & Essences
- Clear Aqueous Toners and Micellar Waters
- Anti-Dark Spot Targeted Treatments
- Daily Radiance Creams and Lotions
- Anti-Aging & Photo-Protection Formulations
Formulation Guidelines
- Incorporation: Add to the cooling phase of emulsions (below 40°C) or directly into the aqueous phase of gels and serums under gentle stirring.
- pH Stability: Optimal performance within a pH range of 4.5 to 7.0.
- Compatibility: Compatible with most cosmetic ingredients; avoid high shear forces post-addition to maintain liposome integrity. Excellent suitability for clear or transparent formulations.
Disclaimer: The information provided is for educational and B2B formulation purposes. Final product claims must be validated by the brand owner according to local cosmetic regulations.
